Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Serum Carbohydrate Antigen 19-9 as an Indicator of Liver Metastasis in Colorectal Carcinoma Cases

  • Dong, Hang (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University) ;
  • Tang, Jie (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University) ;
  • Li, Long-Hao (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University) ;
  • Ge, Jun (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University) ;
  • Chen, Xin (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University) ;
  • Ding, Jing (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University) ;
  • Men, Hai-Tao (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University) ;
  • Luo, Wu-Xia (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University) ;
  • Du, Yang (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University) ;
  • Li, Cong (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University) ;
  • Zhao, Feng (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University) ;
  • Chen, Ye (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University) ;
  • Cheng, Ke (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University) ;
  • Liu, Ji-Yan (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University)
  • Published : 2013.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The liver is the organ to which colorectal carcinomas (CRCs) most commonly metastasize, and surgical resection has been established as the most effective and potentially curative treatment for CRC with liver metastasis (LM). Therefore, surveillance of LM is vital for improvement of prognosis of CRC patients. In this study, we aimed to explore the potential value of carbohydrate antigen 19-9 (CA 19-9), carcinoembryonic antigen (CEA), and marker enzymes in indicating LM with CRC. Methods: Three groups of eligible patients with metastatic cancers were retrospectively included: CRC patients with LM (CRC-LM) or without LM (CRC-NLM), and non-CRC patients with LM (NCRC-LM). All metastatic lesions were identified by CT or MRI. Data on characteristics of the patients, the primary site, the locations of metastasis, CA 19-9, CEA, and biochemical parameters were collected for analysis. Results: A total of 493 patients were retrospectively included. More alcohol consumption was found in CRC-LM than CRC-NLM. Some biochemical enzymes were found to be significantly higher in groups with LM than without (CRC-LM or NCRC-LM v.s CRC-NLM). Both CEA and CA 19-9 were much higher in CRC-LM than CRC-NLM or NCRC-LM. For CRC patients, CA 19-9, ${\gamma}$-glutamyl transpeptidase, CEA and alcohol consumption were identified as independent factors associated with LM. Conclusion: Our analysis suggested the CA 19-9 might be a potential valuable indicator for LM of CRC in the clinic.

Keywords

References

  1. Adam R (2003). Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. Ann Oncol, 14, ii13-6.
  2. Assumpcao L, Choti MA, Gleisner AL, et al (2008). Patterns of recurrence following liver resection for colorectal metastases: effect of primary rectal tumor site. Arch Surg, 143, 743-9. https://doi.org/10.1001/archsurg.143.8.743
  3. Ballehaninna UK, Chamberlain RS (2012). The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal. J Gastrointest Oncol, 3, 105-19.
  4. Brodt P, Fallavollita L, Bresalier RS, et al (1997). Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis. Int J Cancer, 71, 612-9. https://doi.org/10.1002/(SICI)1097-0215(19970516)71:4<612::AID-IJC17>3.0.CO;2-D
  5. Chevinsky AH (1991). CEA in tumors of other than colorectal origin. Semin Surg Oncol, 7, 162-6. https://doi.org/10.1002/ssu.2980070309
  6. Gangopadhyay A, Lazure DA, Thomas P (1998). Adhesion of colorectal carcinoma cells to the endothelium is mediated by cytokines from CEA stimulated Kupffer cells. Clin Exp Metastasis, 16, 703-12. https://doi.org/10.1023/A:1006576627429
  7. Gillams AR, Lees WR (2009). Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol, 19, 1206-13. https://doi.org/10.1007/s00330-008-1258-5
  8. Holt AD, Kim JT, Murrell Z, et al (2006). The role of carcinoembryonic antigen as a predictor of the need for preoperative computed tomography in colon cancer patients. Am Surg, 72, 897-901.
  9. Jaeck D, Oussoultzoglou E, Rosso E, et al (2004). A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg, 240, 1037-49. https://doi.org/10.1097/01.sla.0000145965.86383.89
  10. Kannagi R, Kitahara A, Itai S, et al (1988). Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing epitopes consisting of sialyl or sialyl-fucosyl type 1 chain. Cancer Res, 48, 3856-63.
  11. Koike M, Yasui K, Torii A, et al (2000). Prognostic significance of entrapped liver cells in hepatic metastases from colorectal cancer. Ann Surg, 232, 653-7. https://doi.org/10.1097/00000658-200011000-00006
  12. Levy M, Visokai V, Lipska L, et al (2008). Tumor markers in staging and prognosis of colorectal carcinoma. Neoplasma, 55, 138-42.
  13. Lin PC, Lin JK, Lin CC, et al (2012). Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis. Int J Colorectal Dis, 27, 1333-8. https://doi.org/10.1007/s00384-012-1447-1
  14. Locker GY, Hamilton S, Harris J, et al (2006). ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol, 24, 5313-27. https://doi.org/10.1200/JCO.2006.08.2644
  15. Lumachi F, Marino F, Orlando R, et al (2012). Simultaneous multianalyte immunoassay measurement of five serum tumor markers in the detection of colorectal cancer. Anticancer Res, 32, 985-8.
  16. Maeda M, Nagawa H, Maeda T, et al (1998). Alcohol consumption enhances liver metastasis in colorectal carcinoma patients. Cancer, 83, 1483-8. https://doi.org/10.1002/(SICI)1097-0142(19981015)83:8<1483::AID-CNCR2>3.0.CO;2-Z
  17. Min BS, Lee KY, Park JK, et al (2002). Radiofrequency Ablation of Hepatic Metastasis from Colorectal Cancer; Early Experience. J Korean Surg Soc, 62, 145-9.
  18. Mitsuyama Y, Shiba H, Haruki K, et al (2012). Carcinoembryonic antigen and carbohydrate antigen 19-9 are prognostic predictors of colorectal cancer with unresectable liver metastasis. Oncol Lett, 3, 767-71.
  19. Moolgavkar SH, Holford TR, Levy DT, et al (2012). Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000. J Natl Cancer Inst, 104, 541-8. https://doi.org/10.1093/jnci/djs136
  20. Nakamori S, Kameyama M, Imaoka S, et al (1993). Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res, 53, 3632-7.
  21. Nicolini A, Caciagli M, Zampieri F, et al (1995). Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse. Cancer Detect Prev, 19, 183-95.
  22. Obrador E, Carretero J, Ortega A, et al (2002). gamma-Glutamyl transpeptidase overexpression increases metastatic growth of B16 melanoma cells in the mouse liver. Hepatology, 35, 74-81. https://doi.org/10.1053/jhep.2002.30277
  23. Petrioli R, Licchetta A, Roviello G, et al (2012). CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab. Cancer Invest, 30, 65-71. https://doi.org/10.3109/07357907.2011.629380
  24. Prabasheela B, Baskaran S, Arivazhagan A (2012). Evaluation of alkaline phosphatase in pre and post operative breast cancer patients. Int J Biol Med Res, 3, 1536-7.
  25. Rosenberg MA, Feuer EJ, Yu B, et al (2012). Chapter 3: Cohort life tables by smoking status, removing lung cancer as a cause of death. Risk Anal, 32, S25-38. https://doi.org/10.1111/j.1539-6924.2011.01664.x
  26. Sasaki A, Kawano K, Inomata M, et al (2005). Value of serum carbohydrate antigen 19-9 for predicting extrahepatic metastasis in patients with liver metastasis from colorectal carcinoma. Hepatogastroenterology, 52, 1814-9.
  27. Sato H, Usuda N, Kuroda M, et al (2010). Significance of serum concentrations of E-selectin and CA19-9 in the prognosis of colorectal cancer. Jpn J Clin Oncol, 40, 1073-80. https://doi.org/10.1093/jjco/hyq095
  28. Simic T, Dragicevic D, Savic-Radojevic A, et al (2007). Serum gamma glutamyl-transferase is a sensitive but unspecific marker of metastatic renal cell carcinoma. Int J Urol, 14, 289-93. https://doi.org/10.1111/j.1442-2042.2006.01719.x
  29. Takada A, Ohmori K, Yoneda T, et al (1993). Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res, 53, 354-61.
  30. Van Tilborg AA, Meijerink MR, Sietses C, et al (2011). Long-term results of radiofrequency ablation for unresectable colorectal liver metastases: a potentially curative intervention. Br J Radiol, 84, 556-65. https://doi.org/10.1259/bjr/78268814
  31. Wang WS, Lin JK, Chiou TJ, et al (2002). CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer. Hepatogastroenterology, 49, 160-4.
  32. Yang SH, Lin JK, Lai CR, et al (2004). Risk factors for peritoneal dissemination of colorectal cancer. J Surg Oncol, 87, 167-73. https://doi.org/10.1002/jso.20109

Cited by

  1. MicroRNA-451 Inhibits Growth of Human Colorectal Carcinoma Cells via Downregulation of Pi3k/Akt Pathway vol.14, pp.6, 2013, https://doi.org/10.7314/APJCP.2013.14.6.3631
  2. Survival Outcomes of Liver Metastasectomy in Colorectal Cancer Cases: A Single-Center Analysis in Turkey vol.15, pp.13, 2014, https://doi.org/10.7314/APJCP.2014.15.13.5195
  3. Down-regulated MYH11 Expression Correlates with Poor Prognosis in Stage II and III Colorectal Cancer vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7223
  4. Prognostic and predictive response factors in colorectal cancer patients: Between hope and reality vol.20, pp.41, 2014, https://doi.org/10.3748/wjg.v20.i41.15049
  5. KIAA0101 mRNA overexpression in peripheral blood mononuclear cells acts as predictive marker for hepatic cancer vol.35, pp.3, 2014, https://doi.org/10.1007/s13277-013-1353-3
  6. Factors Affecting Prognosis in Metastatic Colorectal Cancer Patients vol.16, pp.7, 2015, https://doi.org/10.7314/APJCP.2015.16.7.3015